|
RNF216L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.51495999999307E-05 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.668500E-02 |
| Stage1-vs-Stage3 |
4.540400E-01 |
| Stage1-vs-Stage4 |
6.522000E-02 |
| Stage2-vs-Stage3 |
2.040000E-02 |
| Stage2-vs-Stage4 |
3.463800E-03 |
| Stage3-vs-Stage4 |
2.853200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.36580005480636E-09 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
9.627600E-01 |
| Caucasian-vs-Asian |
4.238300E-02 |
| AfricanAmerican-vs-Asian |
2.912400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.55191440096314E-15 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
5.751600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
5.01487740223183E-13 |
| Normal-vs-Age(81-100Yrs) |
5.428700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.296000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.274200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.302800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.579200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.644000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.579200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.44880000000292E-05 |
| Classical-VS-Follicular |
1.560190E-02 |
| Classical-VS-Other |
4.052800E-01 |
| Classical-VS-Normal |
1.6242562850266E-12 |
| Tall-VS-Follicular |
8.63469999945465E-07 |
| Tall-VS-Other |
4.114200E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.304020E-02 |
| Follicular-VS-Normal |
5.84110004808736E-09 |
| Other-VS-Normal |
1.64609999997456E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
9.99200722162641E-16 |
| N0-vs-N1 |
2.860200E-02 |
|
|
